期刊文献+

羟基喜树碱包衣纳米脂质体的制备及在小鼠体内组织分布的研究 被引量:21

Preparation of Chitosan Hydrochloride Coated Hydroxycamptothecin Nanoliposomes and Its Tissue Distribution in Mice
下载PDF
导出
摘要 目的研究羟基喜树碱(HCPT)氯化壳聚糖(CS-HCl)包衣纳米脂质体(nanoliposomes)的制备方法,并考察其在小鼠体内的组织分布.方法采用薄膜分散法制备HCPT脂质体,用CS-HCl包衣后乳匀,得到CS-HCl包衣的HCPT纳米脂质体(平均粒径<100nm).除去游离HCPT后,测定其包封率(EE%)、平均粒径、粒径分布及Zeta电位.以5 mg·kg^-1羟基喜树碱的剂量小鼠尾静脉注射HCPT注射液、普通HCPT脂质体、HCPT纳米脂质体、包衣HCPT纳米脂质体,测定血浆及肝、脾组织中的血药浓度.结果包衣HCPT纳米脂质体的EE%为(61.2±1.20)%,平均粒径为(91.9±8.78)nm,Zeta电位为(55.1±1.04)mV(n=3).包衣HCPT纳米脂质体在血液中AUC0~48为HCPT纳米脂质体的1.3倍,为普通HCPT脂质体的4.7倍,为注射液的25.4倍.AUCplasma/AUCRES表明,包衣HCPT纳米脂质体为HCPT纳米脂质体的1.4倍,为普通脂质体的8.7倍,为注射液的3.4倍.结论该包衣HCPT纳米脂质体具有大小均匀,带有较大正电荷,能显著延长药物在血液循环中的时间,减少RES对脂质体的吞噬作用等特点. OBJECTIVE To investigate the preparation of hydroxycamptothecin(HCPT) nanoliposomes coated by chitosan hydrochloride (CS-HC1) and its tissue distribution in mice . METHODS JCPT nauuliposomes were prepared by tbe film dispersion method followed by chitosan hydrochloride coating, The liposomes were extruded to obtain the particle size below 100 nm. Liposomes contained HCPT and free HCPT were separated by a Sephadex - G50 chromatography. Ultraviolet spectrophotometry was used to determine the entrapment efficiency ( EE % ). The Zeta potential, average size and size distribution of the HCPF liposomes were also detected. HCPT injection, traditional HCPT liposomes, non-coated HCPT nannliposomes and CS-HCI coated HCPT nanoliposomes were injected in tail vein at a dose of 5 mg·kg^-1 of HCPT, respectively. The HPLC-FLD was utilized for the determination of HCPF concentration in mice tissue, including plasma, liver and spleen. RESULTS The average EE % of the CS-HCI coated HCPT nanolipo,somes was(61.2 ± 1.20) %. The average size was (91.9 ± 8.78) nm with the Zeta potential of (55.1 ± 1.04)mV ( n = 3). The area under the curve (AUC0-48 )of plasma of CS-HCI coated H CPT nanoliposomes was 1.3-fold of that of the non-coated nanuliposomes while 4.7-fold of that of the traditiunal liposomes and 25.4-fold of that of the HCPT injection. The ratio of AUCplasma/ AUCRES of CS-HCI coated tfCPT nanoliposomes was 1.4-tbld of that of the non-coated nanoliposomes while 8.7-fold of that of the traditional liposomes and 3.4- fold of that of the HCPT injection. CONCLUSION The results suggest that CS-HCI coated HCPT nanoliposomes have uniform sizes below nauometer degree and high pusitive Zeta potential. The AUC0-48 of plasma is increased significantly and a longer circulation time is obtained after being coated by CS-HCI.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第3期196-200,共5页 Chinese Pharmaceutical Journal
关键词 羟基喜树碱 氯化壳聚糖 纳米脂质体 组织分布 hydroxycamptothecin chitosan hydrochloride nanoliposomes tissue distribution
  • 相关文献

参考文献2

二级参考文献24

  • 1Banakar UV. Advances and opportunities on delivery of therapeutic proteins and peptides [ J ]. J Biomater Appl,1997,11 (4) :377 -429.
  • 2Artursson P, Lindmark T, Davis SS, et al. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells ( Caco-2 ) [ J ]. Pharm Res, 1994, 11 (9) :1358 - 1361.
  • 3Bernkop-Schnürch A, Paikl C, Valenta C. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkepHalin from degradation by aminopeptidase N [ J ].Pharm Res, 1997,14(7) :917 -922.
  • 4Bernkop-Schnürch A, Scerbe-Saiko A. Synthesis and in vitro evaluation of chitosan-EDTA-protease inhibitor conjugates which might be useful in oral delivery of peptides and proteins [ J ]. Pharm Res, 1998,15 (2):263 - 269.
  • 5Berukop-Schnürch A, Krajicek ME. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosanEDTA conjugates [ J ]. J Controlled Release, 1998,50(1 -3) :215 -223.
  • 6Ziv E, Lior O, Kidron M. Absorption of protein via the intestinal wall [ J ]. Biochem Pharm 1987, 36 ( 7 ):1035 - 1039.
  • 7Jung Y J, Lee JS, Kim HH, et al. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colonspecific prodrug of 5-aminosalicylic acid [ J ]. Arch Pharm Res, 1998,21(2) :174 -178.
  • 8Damge C, Michel C, Aprahamian M, et al.Nanocapsules as carriers for oral peptide delivery [ J ]. J Controlled Release, 1990,13 (2 - 3 ): 233 - 239.
  • 9Mathiowitz E, Jacob JS, Jong YS, et al. Biologically erodable microspheres as potential oral drug delivery systems [J]. Nature, 1997,386(6623):410 -414.
  • 10Ba DY. Modern Immuno-technique and Application (当代免疫技术与应用 ) [ M ]. Beijing: Beijing Medical University and Peking Union Medical College Press,1998. 388.

共引文献61

同被引文献284

引证文献21

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部